Fermer le menu

Member of Lyonbiopole


Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s portfolio of injectable treatments for diabetes, featuring five clinical-stage products and three preclinical products, is among the largest and most differentiated of the industry.


Strategic application domain: Human Medicine

Application market: Metabolic Disorders - Endocrinology, Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on dec. 22nd, 2005 - 100 employees



115 avenue Lacassagne 69003 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.